The association between DNA copy number aberrations at chromosome 5q22 and gastric cancer

PLoS One. 2014 Sep 11;9(9):e106624. doi: 10.1371/journal.pone.0106624. eCollection 2014.

Abstract

Background: Gastric cancer is common cancer. Discovering novel genetic biomarkers might help to identify high-risk individuals. Copy number variation (CNV) has recently been shown to influence risk for several cancers. The aim of the present study was sought to test the association between copy number at a variant region and GC.

Methods: A total of 110 gastric cancer patients and 325 healthy volunteers were enrolled in this study. We searched for a CNV and found a CNV (Variation 7468) containing part of the APC gene, the SRP19 gene and the REEP5 gene. We chose four probes targeting at APC-intron8, APC-exon9, SRP19 and REEP5 to interrogate this CNV. Specific Taqman probes labeled by different reporter fluorophores were used in a real-time PCR platform to obtain copy number. Both the original non-integer data and transformed integer data on copy number were used for analyses.

Results: Gastric caner patients had a lower non-integer copy number than controls for the APC-exon9 probe (Adjusted p = 0.026) and SRP19 probe (Adjusted p = 0.002). The analysis of integer copy number yielded a similar pattern although less significant (Adjusted p = 0.07 for APC-exon9 probe and Adjusted p = 0.02 for SRP19 probe).

Conclusions: Losses of a CNV at 5q22, especially in the DNA region surrounding APC-exon 9, may be associated with a higher risk of gastric cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenomatous Polyposis Coli Protein / genetics*
  • Chromosomes, Human, Pair 5 / genetics
  • DNA Copy Number Variations / genetics*
  • Genetic Association Studies*
  • Helicobacter pylori
  • Humans
  • Membrane Proteins
  • Signal Recognition Particle
  • Stomach Neoplasms / genetics*
  • Stomach Neoplasms / pathology

Substances

  • Adenomatous Polyposis Coli Protein
  • Membrane Proteins
  • REEP5 protein, human
  • SRP19 protein, human
  • Signal Recognition Particle

Grants and funding

This work was supported by grants from the Kaohsiung Medical University Hospital (KMUH98-8I04, KMUH98-8G05, KMUH99-9R03), Excellence for Cancer Research Center Grant through the funding from the Department of Health, Executive Yuan, Taiwan, Republic of China (MOHW103-TD-B-111-05), and the National Science Council of the Republic of China (NSC 99-2320-B-037-014-MY3, NSC 94-2314B037-104). The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.